Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer

• Principais autores: Masatoshi Maki (Autor), Ryo Takada (Autor), Akihiko Taniguchi (Autor), Naoyuki Nomura (Autor), Seiichiro Kuramoto (Autor), Yuki Chiko (Autor), Toshiaki Okada (Autor), Seiji Saito (Autor), Koji Tamura (Autor)
• Formato: Livro
• Publicado em: BMC, 2022-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background COVID-19 has become a significant health threat and a primary healthcare concern among the most vulnerable patients with cancer. Patients with COVID-19 who have lung cancer are at great risk and need careful monitoring if they are affected. This study aimed to investigate the cli...